Many treatments are available, and with the popularity of online and mail-order services in recent years, two leaders are BlueChew and Hims. Both companies offer different ED treatments and a ...
Hims & Hers is shutting down the dermatology business it acquired four years ago, Business Insider has learned. On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer ...
Hosted on MSN23d
Why Is Hims & Hers Health (HIMS) Stock Rocketing Higher TodayHims & Hers Health’s shares are extremely ... But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas ...
StockStory.org on MSN18d
Hims & Hers Health (NYSE:HIMS) Beats Q4 Sales Targets But Stock Drops 16%Telehealth company Hims & Hers Health (NYSE:HIMS) announced in Q4 CY2024, with sales up 95.1% year on year to $481.1 million. On top of that, next quarter’s revenue guidance ($530 million at the ...
Hims & Hers Health's stock has surged 205% since ... in website and mobile application development and internal-use software" investments in CapEx) gives the stock a price/FCF multiple of ~105x ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback